Patents Assigned to Roche Diagnostics GmbH
  • Patent number: 7799578
    Abstract: The invention concerns a device and method for withdrawing samples of liquid samples for analytical elements. The device includes a carrier and a cover with a surface that cooperates with a surface of the carrier to form a channel. The channel has an opening defined by at least one edge. At least one notch in the form of a partial groove extends into the at least one edge of the opening so that one side of the edge of the opening is at least partially interrupted by the at least one notch. The notch forms a sample application opening by exposing the surface, whose extension forms an inner surface of the channel.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: September 21, 2010
    Assignee: Roche Diagnostics GmbH
    Inventor: Volker Zimmer
  • Patent number: 7759107
    Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90% of its activity after incubation for two hours at 95° C. in the presence of stabilizing agents and possesses 3?-5? proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR).
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: July 20, 2010
    Assignee: Roche Diagnostics GmbH
    Inventors: Waltraud Ankenbauer, Vitaly Svetlichny, Elizaveta Bonch-Osmolovskaya, Christine Ebenbichler, Bernhard Angerer, Gudrun Schmitz-Agheguian, Frank Laue
  • Publication number: 20100136519
    Abstract: The invention concerns a process for the immunological determination of a specific antibody in a fluid sample. The process involves incubating the fluid sample in the presence of a solid phase with two antigens directed against the antibody whose presence is to be determined; the first antigen carries at least one marker group, while the second is either (a) bonded to the solid phase or (b) present in a form in which it can bond with the solid phase, and betrays the presence of the antibody being sought by showing the presence of the marker group in the solid phase and/or in the fluid phase. The proposed process is characterised by the fact that at least one of the two antigens has several epitopic regions which react with the antibody to be determined.
    Type: Application
    Filed: October 27, 2009
    Publication date: June 3, 2010
    Applicant: Roche Diagnostics GmbH
    Inventors: Ursula-Henrike Wienhues, Cornelia Kruse-Müller, Eva Höss, Elke Faatz, Beatus Ofenloch-Hähnle, Christoph Seidel, Michael Wiedmann
  • Publication number: 20100074946
    Abstract: The invention relates to a nucleic acid preparation with a content of below 1% protein, preferably below 0.1% protein, free of ethidium bromide, phenol, cesium chloride and detergents based on octyl phenol poly(ethylene glycol ether)n and with a content of below 1EU/mg DNA of endotoxins. Said preparation is suitable as a drug particularly in gene therapy.
    Type: Application
    Filed: November 30, 2009
    Publication date: March 25, 2010
    Applicant: Roche Diagnostics GmbH
    Inventor: Wolfgang KUHNE
  • Patent number: 7659373
    Abstract: The invention concerns new EPO compositions with high specific activity which are characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure. In addition the invention concerns a process for producing such EPO products.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: February 9, 2010
    Assignee: Roche Diagnostics GmbH
    Inventors: Josef Burg, Karl-Heinz Sellinger, Anton Haselbeck, Hans Koll
  • Patent number: 7629295
    Abstract: The invention concerns a method for the immunological determination of a specific antibody in a sample liquid in which the sample liquid is incubated in the presence of a solid phase with two antigens directed against the antibody to be determined of which the first antigen carries at least one marker group and the second antigen is (a) bound to the solid phase or (b) is present in a form capable of binding to the solid phase and the antibody to be determined is detected by determining the marker group in the solid phase or/and in the liquid phase characterized in that at least one of the two antigens contains several epitope regions which react with the antibody to be determined.
    Type: Grant
    Filed: July 7, 2003
    Date of Patent: December 8, 2009
    Assignee: Roche Diagnostics GmbH
    Inventors: Ursula-Henrike Wienhues, Cornelia Kruse-Müller, Eva Höss, Elke Faatz, Beatus Ofenloch-Hähnle, Christoph Seidel, Michael Wiedmann
  • Patent number: 7612187
    Abstract: Within oligonucleotides 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: November 3, 2009
    Assignee: Roche Diagnostics, GmbH
    Inventors: Frank Seela, Helmut Rosemeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann
  • Patent number: 7569187
    Abstract: A method and a device for removing an analytic consumable product, in particular a test element, from a storage container having chambers which are sealed by foils from which the consumable product is pushed out by means of a plunger (7) can be optimized in that the magnitude of the thrusting force exercised by the plunger (7) during its forward motion can be controlled in dependence on the plunger (7) position.
    Type: Grant
    Filed: October 1, 2002
    Date of Patent: August 4, 2009
    Assignee: Roche Diagnostics GmbH
    Inventors: Michael Schabbach, Karl Miltner, Thomas Klemm, Rolf Baumann, Meinrad Dilger
  • Publication number: 20090191558
    Abstract: The present invention relates to new nucleic acid sequences derived from the ITS (Internal Transcribed Spacer) region, between the 16S and 23S rRNA genes, to be used for the specific detection and/or identification of Serratia species, in particular of Serratia marcescens, Serratia ficaria and/or Serratia fonticola, in a biological sample. The present invention relates also to a method for the specific detection and/or identification of Serratia species, in particular Serratia marcescens, Serratia ficaria and/or Serratia fonticola, using said new nucleic acid sequences derived from the ITS region. It relates also to nucleic acid primers to be used for the amplification of said spacer region of Serratia species in a sample.
    Type: Application
    Filed: December 9, 2008
    Publication date: July 30, 2009
    Applicants: Innogenetics, N.V., Roche Diagnostics GmbH
    Inventors: Geert JANNES, Wouter Mijs, Thomas Emrich, Gerd Haberhausen
  • Patent number: 7547417
    Abstract: A storage container for holding analytical devices, the storage container being made of a rigid material and containing separate chambers in each of which at most one analytical device can be accommodated, wherein the chambers are in a regular geometric arrangement in relation to one another and each of the chambers has at least two opposite openings each sealed by a foil, wherein at least one of the chambers comprises a means for fixing the position of an analytical device in the chamber. In addition the invention concerns a system for storing analytical devices containing a storage container according to the invention and two or more analytical devices.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: June 16, 2009
    Assignee: Roche Diagnostics GmbH
    Inventor: Klaus-Dieter Sacherer
  • Publication number: 20090093043
    Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90% of its activity after incubation for two hours at 95° C. in the presence of stabilizing agents and possesses 3?-5? proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR).
    Type: Application
    Filed: June 9, 2008
    Publication date: April 9, 2009
    Applicant: Roche Diagnostics GmBH
    Inventors: Waltraud Ankenbauer, Vitaly Svetlichny, Elizaveta Bonch-Osmolovskaya, Christine Ebenbichler, Bernhard Angerer, Gudrun Schmitz-Agheguian, Frank Laue
  • Patent number: 7479253
    Abstract: A flat-shaped functional overlay for at least one region of a flat-shaped flexible object which does not form a fold when the sandwich composed of the flexible object and overlay is bent towards the side on which the overlay is located is described. The overlay is composed of one or several flat-shaped overlays which are attached to the flexible object in such a way that a part of their surface can move freely relative to the surface of the object covered by this part in the direction of curvature produced when the object is bent. In addition diagnostic test strips are described which have such an overlay.
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: January 20, 2009
    Assignee: Roche Diagnostics GmbH
    Inventors: Wolfgang-Reinhold Knappe, Helmut Leininger, Ralf Steinbrueck, Franz Wittmann
  • Publication number: 20080286280
    Abstract: The invention concerns lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies which contain a sugar or an amino sugar, an amino acid and a surfactant as stabilizers. In addition the invention concerns a process for the production of this stable lyophilisate as well as the use of a sugar or amino sugar, an amino acid and a surfactant as stabilizers for therapeutic or diagnostic agents containing antibodies.
    Type: Application
    Filed: July 28, 2008
    Publication date: November 20, 2008
    Applicant: Roche Diagnostics GmbH
    Inventors: Georg KALLMEYER, Gerhard Winter, Christian Klessen, Heinrich Woog
  • Patent number: 7429468
    Abstract: The present invention relates to thermostable mutants of B-type DNA polymerases comprising a Y-GG/A amino acid motif between the N-terminal 3?-5?-exonuclease domain and the C-terminal polymerase domain whereas the tyrosine of the Y-GG/A amino acid motif is mutated and whereas these mutant DNA polymerases are suitable for PCR.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: September 30, 2008
    Assignee: Roche Diagnostics GmbH
    Inventors: Harald Sobek, Bruno Frey, Garabed Antranikian, Boehlke Kristina, Francesca Maria Pisani, Mosè Rossi
  • Patent number: 7425423
    Abstract: A purified thermostable enzyme is derived from the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90% of its activity after incubation for two hours at 95° C. in the presence of stabilizing agents and possesses 3?-5? proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR).
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: September 16, 2008
    Assignee: Roche Diagnostics GmbH
    Inventors: Waltraud Ankenbauer, Vitaly Svetlichny, Elizaveta Bonch-Osmolovskaya, Christine Ebenbichler, Bernhard Angerer, Gudrun Schmitz-Agheguian, Frank Laue
  • Patent number: 7410782
    Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Archaeoglobus fulgidus. The enzyme can be native or recombinant, is stable under PCR conditions and exhibits double strand specific exonuclease activity. It is a 3?-5? exonuclease and cleaves to produce 5?-mononucleotides. Thermostable exonucleases are useful in many recombinant DNA techniques, in combination with a thermostable DNA polymerase like Taq especially for nucleic acid amplification by the polymerase chain reaction (PCR).
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: August 12, 2008
    Assignees: Roche Diagnostics GmbH, Roche Molecular Systems, Inc.
    Inventors: Waltraud Ankenbauer, Frank Laue, Harald Sobek, Michael Greif
  • Publication number: 20080187904
    Abstract: The invention concerns a process for the production of metal chelate-labelled peptide antigens, peptides obtainable by this process and their use in an immunological method of detection.
    Type: Application
    Filed: February 6, 2008
    Publication date: August 7, 2008
    Applicant: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Eva Hoss
  • Patent number: 7390624
    Abstract: The invention concerns a process for the production of metal chelate-labelled peptide antigens, peptides obtainable by this process and their use in an immunological method of detection.
    Type: Grant
    Filed: February 10, 2003
    Date of Patent: June 24, 2008
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Eva Höss
  • Patent number: 7371830
    Abstract: Magnetic particles are prepared containing a magnetic core coated with a glass layer having a substantially pore-free glass surface or having pores with a diameter of less than 10 nm. The particles are used for separating biological material such as nucleic acids. A preferred process of preparing the particles is by forming a mixture of magnetic cores with a sol formed from an alcohol and a metal alkoxide, spray-drying the mixture to coat the cores with a layer of gelled sol, and heating the coated cores to obtain the magnetic glass particles. Preferably, the particles have an average particle size of less than 100 ?m. The magnetic core may be a composite material containing a mica core and magnetite particles immobilized on the mica core, and the glass layer may contain boron oxide. Magnetic core materials include magnetite (Fe3O4) and Fe2O3.
    Type: Grant
    Filed: January 24, 2005
    Date of Patent: May 13, 2008
    Assignee: Roche Diagnostics GmbH
    Inventors: Jörg Kleiber, Thomas Walter, Herbert Harttig, Christop Lesniak, Martin Mennig, Michael Riedling, Helmut Schmidt
  • Patent number: 7347971
    Abstract: A spreading material is described which comprises a porous flat-shaped structure impregnated with a wetting agent, wherein the wetting agent is N-oleoyl-sarcosinate.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: March 25, 2008
    Assignee: Roche Diagnostics GmbH
    Inventor: Wolfgang-Reinhold Knappe